Healthcare
Mobeus invests £3.5m in Bourn
Mobeus Equity Partners has made an investment of £3.5m in Bourn Bioscience, a UK-based operator of in-vitro fertilisation (IVF) clinics that trades under the name Bourn Hall Clinic.
Montagu acquires Rexam divisions for $805m
Montagu Private Equity has acquired the healthcare devices and prescription retail divisions of UK consumer packaging company Rexam for $805m in cash.
VC-backed Egalet files $45.5m IPO
UK-based pharma company Egalet, backed by a consortium of venture capital firms, is seeking to raise up to $45.5m in its IPO on the Nasdaq.
Hutton Collins injects €50m into Dedalus
Hutton Collins has made a €50m investment in Dedalus, an Italian healthcare IT systems provider, along with a further €15m from co-investors.
IK’s Attendo rumoured to list this year
IK Investment Partners could list Swedish elderly care provider Attendo on the Stockholm exchange this year, according to media reports.
Octopus supports Michelson Diagnostics
Octopus Investments has led a £1.98m round for existing portfolio company Michelson Diagnostics, a UK-based medical devices company.
VC-backed Lombard to leave AIM for Nasdaq
Lombard Medical Technologies, a London-based medical devices company backed by Abingworth Management and MVM Life Science Partners, is planning to delist from the London Stock Exchange’s AIM and relist on the Nasdaq.
Deal in focus: VC-backed Okapi sold to US biopharma Aratana
The sale of venture-backed Belgian biopharmaceutical company Okapi Sciences to listed US biopharma Aratana Therapeutics highlights the benefits that come from maintaining relationships with former fellow investors.
Erhvervsinvest backs Scanbur
Erhvervsinvest has invested in Danish life sciences company Scanbur.
Gilde acquires Viroclinics
Gilde Healthcare Services has acquired a majority stake in Viroclinics Biosciences, a Netherlands-based virology contact research organisation (CRO).
VC-backed Okapi acquired by US biopharma Aratana
Belgian biopharmaceutical company Okapi Sciences, backed by several venture capital firms, has been acquired by listed US biopharma Aratana Therapeutics for a total consideration of up to €33.3m.
Turkven buys Carlyle’s stake in Medical Park
Turkish private equity firm Turkven has acquired Carlyle’s 40% stake in hospital chain Medical Park.
VC-backed uniQure files $75m IPO
Dutch gene therapy company uniQure, backed by several venture capital firms, plans on raising up to $75m in its IPO on the Nasdaq.
Imperial increases investment in TopiVert
Imperial Innovations has injected a further £4.5m into existing portfolio company TopiVert, a UK-based developer of treatments for inflammatory eye and gut diseases.
Enterprise Ireland et al. back Metabolomic
Enterprise Ireland, SOSVentures and the AIB Seed Capital Fund have injected €750,000 into the series-A funding round of Ireland-based Metabolomic Diagnostics.
BGF injects £6m into Medicina
The Business Growth Fund (BGF) has invested £6m in Bolton-based medical devices company Medicina.
Crescendo Biologics secures £17.5m series-A
UK biotech Crescendo Biologics has raised £17.5m in its series-A funding round from Imperial Innovations, Astellas Venture Management (AVM) and existing investor Sofinnova Partners.
Deutsche Private Equity buys Zellbios from Ergon
Deutsche Private Equity (DPE) has acquired Luxembourg-based pharmaceuticals firm Zellbios from Ergon Capital Partners.
Forbion et al. back Ario Pharma
Forbion Capital Partners, Seroba Kernel Life Sciences and New Science Ventures (NSV) have injected £1.9m into UK biotech Ario Pharma.
Bridgepoint Development Capital picks up Quotient
Bridgepoint Development Capital (BDC) has acquired outsourced drug development business Quotient Clinical from Quotient Bioresearch Group.
Seventure et al. back EndoControl
Seventure Partners, CM-CIC Capital Innovation and Viveris Management have injected €4m into EndoControl, a French surgical robotics developer.
Gimv et al. invest CHF 42m in Covagen
Swiss biotech business Covagen has secured CHF 42m for its series-B funding round from a consortium of venture capital firms led by Gimv.
Omnes et al. invest €8m in Gecko Biomedical
Omnes Capital, CM-CIC Capital Finance and CapDecisif Management have backed an €8m series-A round for Paris-based medical devices company Gecko Biomedical.
Cinven's Amco in bolt-on
Cinven portfolio company Amdipharm Mercury (Amco) has acquired Abcur, a Swedish pharmaceutical business.